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Despite the growth of traditional Chinese medicine (TCM) and western herbal medicine (WHM) research in Australia, little is
known about how ethics committees (HRECs) assess the ethics of TCM or WHM research. The objectives of this study were to
examinetheexperiences ofTCM andWHM researchers andHRECs withtheevaluationofethics applications.Two cross-sectional
surveyswereundertakenofHRECsandTCMandWHMresearchers inAustralia.Anonymousself-completionquestionnaireswere
administered to 224 HRECs and 117 researchers. A response conﬁrming involvement in TCM or WHM research applications was
received from 20 HRECs and 42 researchers. The most frequent ethical issues identiﬁed by HRECs related to herbal products
including information gaps relating to mode of action of herbal medicines and safety when combining herbal ingredients.
Researchers concurred that they were frequently requested to provide additional information on multiple aspects including safety
relating to the side eﬀects of herbs and herb-drug interactions. Overall adherence with the principles of ethical conduct was high
among TCM and WHM researchers although our study did identify the need for additional information regarding assessment of
risk and risk management.
1.Introduction
Complementary Medicine (CM) is an inclusive term that
incorporates complementary medicines and complementary
therapies (modalities and or systems). We use this term to
includethe conceptsofhealth and medical systems, practices
and products not currently recognised as part of mainstream
conventional or mainstream medicine, alternative medicine
(CM used in place of Western medicine), traditional
medicine (indigenous medicine and practices), and integra-
tive medicine (CM used together with mainstream Western
medicine) [1]. Worldwide there is growing use of CM. The
World Health Organisation estimates that80% of theworld’s
population depends on use of CM, including traditional
indigenous medicines. Use of CM in the United States of
America has been reported to be 36%, or 62% if prayer and
mega vitamins are included [2]. In Australia, use of CM
has increased steadily over the last twenty years. In 2006,
the National Prescribing Service national consumer survey
showed a signiﬁcant increase in the proportion of people
taking CM (67%) [3], with self-prescribed vitamins, herbal
medicines, and mineral supplements the most commonly
used CM. A 2006 Australian Bureau of Statistics survey
reported that 3.8% of the population had consulted a CM
practitioner in the previous two weeks, 0.5% had visited
an acupuncturist, and 0.3% a herbalist [4]. A more recent
survey of CM use in Australia indicated 46% used vitamins
not prescribed by a doctor, 19% used herbal medicines, and
6% traditional Chinese medicine (TCM) [5].
Herbal medicines are commonly prescribed in Aus-
tralia to treat a broad range of health conditions. Chinese
herbal medicine, a modality that originated in China, is
prescribed by practitioners qualiﬁed and trained in TCM.
These practitioners are also trained to practise acupuncture.
Western herbal medicine (WHM) is commonly provided by
practitioners trained as Western herbalists or naturopaths
and this modality, as well as the terminology, reﬂects the
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European and American traditions. The uptake of CM in
the community highlights the importance of establishing
a scientiﬁc base for the safety and eﬀectiveness of these
modalities. In Australia, clinical research on TCM and
WHM has mostly been restricted to academic teaching
institutions delivering TCM and WHM tertiary courses, and
a number of hospitals with individual researchers interested
in these disciplines, as well as industry-based researchers. A
survey conducted in 2007 identiﬁed 47 centres, and 253 full
time researchers working in CM research in Australia [6].
Signiﬁcantresearchactivitywas undertakeninthedisciplines
of WHM and TCM, with less research activity within other
CM modalities. In late 2006, the Australian National Health
and Medical Research Council (NHMRC) allocated a $5
million funding to a research grant initiative targeting CM
research. This funding initiative drew a strong response
demonstrating the high level of interest in CM research.
There has been limited attention given to the ethics of
conducting scientiﬁc CM research and practice. In clinical
practice, one qualitative study has indicated a lack of
standards with respect to informed consent across a range
of CM modalities [7]. Whilst commentators contend that
public health and safety demand all CM adhere to the
same ethical standards as for mainstream clinical research,
and placebo controlled trials should be used to assess the
eﬃcacy of complementary treatments where feasible [8,
9], others propose the paradigms of CM including TCM
and WHM cannot be evaluated accurately using placebo
randomised controlled trials. For example, the practices of
TCM and WHM can be described as complex modalities
using multiple interventions with individualised treatments
for each patient. These characteristics do not ﬁt easily
within the placebo control model, and are more suited to
pragmatic trial designs that accommodate complex whole
systems interventions. However, many TCM and WHM
researchers have demonstrated an acceptance that CM can
be rigorously evaluated applying randomised trial designs.
Whilst TCM and WHM present researchers with challenges,
for example, the standardisation of herbal medicines, drug-
herb interactions, use of appropriate placebo controls and
potential adverse events, the ethics of conducting TCM, and
WHM research in principle should not diﬀer from other
areas of health research.
The values of respect, research merit and integrity,
justice, and beneﬁcence, and risk safety assessment have
become important ethical principles with the conduct of
humanresearch. Theseethicalprinciplestheoreticallyshould
not be problematic for TCM or WHM research. However,
as highlighted by Zaslawski 2008, the merit and integrity of
TCMorWHMethicsapplicationsmaypresentchallengesfor
researchers preparingethicsapplications,andethicscommit-
tees responsible for reviewing these applications who may be
unfamiliar with TCM practice principles [10]. Acupuncture
research, using single blind studies and placebo controls
may require engagement in active deception and limited
disclosure between researchers with potential participants.
This may be ethically unacceptable to some researchers and
ethics committees. The risk-safety proﬁle for acupuncture
studies are low [11], however, the safety of Chinese herbs
is less well established [12], although in Australia herbal
products are approved as low risk products.
In 2008,funding wasreceived by theNational Institute of
Complementary Medicine (NICM) to undertake “network
building” in relation to TCM. The aim of this capacity
building project was to enhance research networks in TCM
through creating and coordinating human resources in
clinical trials, phytochemistry, and acupuncture research,
and to develop methodological approaches relevant to these
ﬁelds. The need to build capacity was identiﬁed in response
to the growth and trends in CM research particularly in
herbal medicines, and the need to establish the evidence
base through use of randomised controlled trials. This
initiative identiﬁed a speciﬁc need to build capacity among
appropriately skilled TCM and WHM researchers, and to
assist institutionalethicscommitteeswiththeirassessment of
applications in this new ﬁeld of research. Two speciﬁc areas
were identiﬁed. Firstly, the complexity of TCM and WHM
products with multicomponent ingredients which increases
the complexity in understanding the risks and potential
mechanisms. Secondly, the assessment and understanding of
the low risk of products which are already available over the
counter and therefore approved for human use, or they form
part of the food-herb-drug interface, and the quality control
and stability of herbal products.
In light of the growth of TCM and WHM research
in Australia, little is known about how HRECs assess the
ethics of TCM research, or engage with TCM or WHM
researchers. The objectives of this study were ﬁrstly, to
examine the experiences of HRECs with the evaluation
of TCM and WHM ethics applications, and secondly, to
examine theexperiences ofTCMand WHM researchers with
the submission of their research proposals to HRECs.
2.Subjectsand Methods
2.1. Study Populations. Following ethics approval from The
University of Western Sydney, two concurrent surveys
were undertaken between May and July 2009. Firstly,
all HRECs in Australia were identiﬁed from a listing
held on the NHMRC database (http://www.nhmrc.gov.au/
health ethics/hrecs/hreclist.htm). A survey was sent to the
HRECsand theChairorEthicsOﬃcerwas askedtocomplete
the survey. Secondly, a survey was sent to all identiﬁed
TCM and WHM researchers in Australia. Researchers were
identiﬁed from a listing of active researchers held by NICM,
who had previouslygivenpermission for theircontactdetails
tobeusedforresearch purposes.Inaddition,newresearchers
wereidentiﬁedfromtheAustralianandNewZealandClinical
Trial Registry (http://www.anzctr.org.au/)a n das e a r c ho f
databases publishing in the discipline of TCM and WHM,
for example PubMed (http://www.ncbi.nlm.nih.gov/). All
researchers and HRECs were invited to participate. The
methodological challenges of internet surveys including
lower responses rates [13], and incomplete electronic
addresses for all study participants, inﬂuenced our choice to
administer apostalsurvey.Potentialparticipantsweremailed
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the purpose of the survey. A second followup mail out was
made six weeks after the initial mail out. Participants were
invited to return the questionnaire by email, fax, or using a
reply paid envelope.
2.2. Questionnaire. We designed two short self-completion
questionnaires (see supplmentary material available online
at doi:10.1155/2011/256915). Both questionnaires included
ﬁlter questions to identify responders who had submitted or
reviewed a TCM or WHM ethics application in the previous
three years. The questionnaire for HRECs contained 14
items. The ﬁrst four items included background questions
relating to the total number, and details of TCM or WHM
applications reviewed, for example, modality. The next
section contained items relating to composition of the
HREC including number of members with a background
in TCM or WHM and the evaluation methods used to
assess such research applications. A further section examined
the methodological and ethical complexities relating to
TCM or WHM research, for example, information on
herbal characterisation or standardisation, safety issues with
combining herbal ingredients, or knowledge of traditional
diagnostic methods. The ﬁnal three questions examined the
demographic characteristics of the HREC responder. The
questionnaire also included an open-ended question for
additional comments.
The researchers’ questionnaire consisted of 18 items. The
ﬁrst four items included background questions relating to
the number and details of TCM or WHM ethics applications
submitted. The next section related to the researchers’
experience of submitting TCM or WHM applications to
ethics committees. This included generic questions relat-
ing to the type of feedback received from HRECs, for
example, procedures for gaining consent. Speciﬁc questions
for acupuncturists and herbalists were also included, for
example, requestfor information relating to stability,dosage,
safety, and blinding. The ﬁnal ﬁve questions examined the
demographic characteristics of the responder. The question-
naire also included an open-ended question for additional
comments.
2.3. Statistical Analyses. The statistical analysis was per-
formedusingStatisticalPackagefortheSocialSciences(SPSS
version 17.0). The responses from researchers and HRECs
were analysed separately using descriptive statistics.
3.Results
3.1. Response from HREC. Two hundred and twenty four
questionnaires were sent out to HRECs. A response was
received from 148 committees (66%), of which 20 indicated
they had reviewed at least one TCM or WHM appli-
cation in the previous three years. Responses indicated
representation across Australian States or Territories, with
8 (42%) responses from Victoria, New South Wales 5
(26%), Queensland 3 (16%), South Australia 2 (11%),
and the Australian Capital Territory 1 (5%). Fifteen (79%)
r e s p o n d e r sh a ds e r v e do na nH R E Cf o rg r e a t e rt h a n
Table 1: Modality of traditional Chinese medicine (TCM) or
Westernherbal medicine (WHM)reviewed by HRECs orsubmitted
by a researcher.
Modality of TCM or
WHM submitted
Reviewed by Ethics Submitted by researcher
n = 20 % n = 39 %
Acupuncture 10 50.0 20 51.3
Ingested TCM herbs 10 50.0 13 33.3
Ingested WHM herbs 9 45.0 8 20.5
WHM topically
applied
3 15.0 1 2.6
Therapeutic exercise 4 20.0 3 7.7
Acupressure 1 5.0 2 5.1
Massage 2 10.0 1 2.6
Number (n) and percentage (%).
three years. Membership of the HREC was represented
by a researcher(s) with a health/medical/psychological or
epidemiological background (94%), lawyer (84%), minister
of religion (79%), nurse (73%), clinical psychologist (26%),
social worker (21%), CM researcher (10%), and various
other categories, for example, pharmacist, layperson, and
biostatistician.
3.2. Review of TCM/WHM Applications by HRECs. The
numberofTCMandWHMapplicationsreviewedbyHRECs
was a small proportion of their work. The majority of
HRECs (n = 10, 55%) reviewed 1 to 2 applications, four
committees (22%) reviewed 3 to 5 applications, and four
committeeshad reviewed more than ﬁve (22%)applications.
Eighty-ﬁve percent of HRECs reviewed applications using a
randomised controlled trial (RCT).Over50% of committees
had reviewed applications on acupuncture and ingested
TCM herbs, 45% reviewed ingested WHM, and a smaller
number of applications relating to topically applied WHM,
and therapeutic exercise, for example, Tai chi and qi gong,
acupressure and massage (Table 1).
CapacitytoreviewTCMandWHMapplicationswaswell
represented with nine (45%) HRECs having members with
expertise or knowledge of TCM or WHM. Six committees
had two or more members with TCM or WHM background.
A signiﬁcant proportion of HRECs (16, 80%) were able to
use the experience of committee members or subcommittees
to assist with the evaluation of the scientiﬁc validity of TCM
or WHM applications, or HRECs consulted with personnel
within their institution (8, 40%), or referred to current
literature (7, 35%). The most frequent strategy employed
to address problems raised during the assessment process
included seeking further clariﬁcation or information from
the researcher (18, 94.4%), or requesting alteration to the
study design (9, 47%). Three HRECs dismissed applications
due to a lack of scientiﬁc rigour.
HRECs were asked to comment on the information
provided by researchers on the methodological and ethical
complexities of conducting TCM or WHM research. The
aim of these questions was to identify any information gaps
that may hinder the passage of applications through ethics.4 Evidence-Based Complementary and Alternative Medicine
Table 2:Informationonthemethodologyoftheethicsapplications
assessed by HREC as suﬃcient.
Domain n = 20 %
Blinding or lack thereof 16 80
Mode of action from a scientiﬁc perspective 10 50
Safety issues when combining herbal
ingredients
84 0
Limited phase one and reliance on anecdotal
evidence for safety and dosage
63 0
Individualisation of treatment according to
diagnosis
52 5
Herbal characterisation, standardisation, and
stability
52 5
Knowledge of traditional diagnostic methods 42 0
Description of a complex intervention or
multi modality holistic treatment
42 0
Number (n) and percentage (%).
The responses from HRECs suggest suﬃcient information
was provided by researchers on the blinding of studies
(Table 2). Responses highlighted information gaps detailing
mode of action of herbal medicines, safety when combining
herbal ingredients, reliance on anecdotal evidence for phase
one trials, individualisation of treatment, description of
the complex intervention, and traditional diagnostic meth-
ods. HRECs requested supplementary information from
researchers ondata safety regarding theuse oflaser acupunc-
ture, the need to explain risks to participants, risk of cross-
contamination and the risk of adverse events.
Fifty percent of HRECs had identiﬁed an ethical issue
when reviewing a TCM or WHM application (Table 3).
The most frequent ethical issues identiﬁed related to herbal
products speciﬁcally, assessing the clinical application claims
of formula, and the interaction and eﬀect of combining
herbal ingredients. Other less common ethical concerns
related to the product quality of herbs, Australian regulation
ofthe modality, and conﬂictofinterestofthe researchers due
to their belief in the value of the modality conveyed in their
protocol.
3.3. Submission of TCM and WHM Ethics Applications by
Researchers. Questionnaires were sent to 117 TCM and
WHM researchers, 60 questionnaires were returned (51%),
of which 39 responders indicated they had submitted an
ethics application as a principal investigator within the last
three years. Forty-three percent of researchers responding
to the survey were from New South Wales and 33% from
Victoria, with smaller numbers from three other States
(Table 4). Researchers were mostly male (53%), aged 35–
44 years (41%), and over 64% held a Doctor of Philosophy
(Ph.D.). Due to the anonymous nature of the survey,
limited comparisons could be made between responders
and nonresponders. Sixty eight percent of questionnaires
were sent to male researchers, and a comparison with male
responders suggest no diﬀerence by the sex of the responder
(P = .09).
Table 3: Ethical issues encountered by HREC with reviewing TCM
or WHM applications.
Ethical issue
Yes
n = 20 %
Assessment of clinical application claim of
formula
10 50.0
Interaction and eﬀects of combining herbal
ingredients
10 50.0
Product quality regarding herbal
interventions
7 35.0
Informationregarding Australian regulation
of modality
7 35.0
Conﬂict of interest for research due to belief
in value of their modality
6 30.0
Conﬂict of interest for researchers regarding
transparency of funding
4 20.0
Surveys creating unnecessary anxiety, or
raised expectations
2 10.0
Number (n) and percentage (%).
Table 4: Characteristics of researchers responding to the survey.
Demographic
Researcher
n = 39 %
Response by State
Victoria 13 33.3
New South Wales 17 43.6
Queensland 6 15.4
South Australia 25 . 1
Western Australia 12 . 6
Age (years)
18–34 5 12.9
35–44 16 41.0
45–54 11 28.2
55–64 7 17.9
Highest qualiﬁcation
PhD 25 64.1
Masters 4 10.3
Bachelors with Honours 4 10.3
Bachelors/Graduate Diploma 6 15.4
Number (n) and percentage (%).
Fifty percent of researchers indicated they had submitted
one application to an HREC in the past three years, six
(16%) had submitted two applications, and eight (22%)
indicated ﬁve or more submissions had been made. Over
50% of researchers had submitted an ethics application on
acupuncture, fewer applications were submitted on ingested
T C Ma n dW H Mh e r b s ,a n do t h e rm o d a l i t i e s ,a n d8 0 %
of applications were RCT designs (Table 1). Researchers’
responses suggest a greater number of acupuncture submis-
sions were made to HRECs compared with the numbers
reportedly assessed by HREC. The proportion of other TCMEvidence-Based Complementary and Alternative Medicine 5
Table 5: Requests for further information to support researchers
ethics applications.
Chinese herbal or Western herbal
medicine researchers
Yes
N = 24 %
Safety for herb-drug interaction 12 50.0
Side eﬀects of herbs 12 50.0
Dosage levels 8 32.0
Interaction and cumulative
eﬀects of combined herbs when
using formulas
7 28.0
Characterisation to quantify
chemical constituents
5 20.8
Standardisation of therapeutic
active compound
4 16.0
Stability and shelf life 28 . 0
Acupuncture researchers N = 22 %
Safety of acupuncture and
potential risks
9 40.9
Assessment of blinding 7 31.8
Clariﬁcation of sham
acupuncture
6 27.3
Action of speciﬁc acupuncture
points
29 . 1
Clariﬁcation of term diﬀerential
diagnosis
29 . 1
Number (n) and percentage (%).
andWHMmodalitiessubmittedbyresearchers andreviewed
by HRECs were similar.
Most researchers were requested to provide additional
information to support their ethics application (Table 5).
Two areas were frequently identiﬁed by herbal medicine
researchersasrequiringadditionalinformationincludingthe
side eﬀects of herbs, and safety for herb-drug interactions.
Other areas included dosage levels and interaction and
cumulativeeﬀectsofcombinedherbalingredients.Acupunc-
turists were requested to provide additional information on
the safety of acupuncture and potential risks, blinding, and
clariﬁcation of placebo acupuncture.
Over forty percent of researchers reported they had been
requested by an HREC to amend their study protocol, this
included changes to exclusion criteria, details on potential
adverse events, or risks and procedures. Two responders
(1.7%) indicated ethics approval had not been given to all
of their TCM or WHM research. Many researchers received
generic feedback requesting clariﬁcation or changes to their
application. Examples included clariﬁcation or changes to
language used on information sheets (47%), language used
on consent forms (44%), procedures for gaining consent
(36%), assessment of the study population (34%), and
maintaining the scientiﬁc validity of their research (13%).
Other examples included clariﬁcation regarding potential
side eﬀects, the need for indemnity insurance, role of
investigators, and recruitment strategies.
The survey identiﬁed a need amongst researchers to
receive further training to assist with preparation of ethics
applications. Almost 80% of researchers reported their
knowledge or conﬁdence with preparing ethics applications,
or responding to questions from ethics could be improved.
The majority ofHRECsand researchers identiﬁed an interest
in receiving guidelines or further training.
4.Discussion
This is the ﬁrst study to our knowledge reporting on the
experiences of researchers and HRECs providing insight
into the process of ethical submission and review of TCM
and WHM research. Respondents to this survey include a
small active group of clinical researchers and HRECs which
r e ﬂ e c t sT C Ma n dW H Mb e i n gc o n c e n t r a t e dw i t h i nal i m i t e d
number of academic institutions in Australia.
The primary purpose of the ethical guidelines for
research involving humans is to promote ethically good
human research. These principles of ethical conduct cover
the principals of merit and integrity, justice, beneﬁcence,
respect, risk and beneﬁt, and participants’ consent [14].
Many Australian research institutions conduct a process of
peer review prior to assessment by HRECs for unfunded
research. Competitive research funding is usually peer
reviewedandtogetherthesetwoinstitutionalprocessesassess
the research merit and integrity of the proposed TCM and
WHM research, prior to assessment by the HRECs.
Overall adherence with the principles of ethical conduct
was high among TCM and WHM researchers although
our study did identify some gaps mostly relating to the
assessment of risk and risk management prior to approval
being given. Ethics committees would normally require
information presented on the toxicology, pharmacological
proﬁle and adverse events to evaluate the risk safety beneﬁt
[10]. With the development of pharmaceuticals, a step by
step process of drug testing occurs in which a compound
is isolated, tested in tissue cultures and animals and then
investigated in phase I, II, and III trials in humans. Although
Chinese herbs have been used for many centuries the safety
proﬁle is not well established [12] and it is rare for a strong
preclinical basis for dosing to exist, and reliance is made
on anecdotal evidence. Consequently, further information
may be requestedby HRECsonthe characterisation, toxicity,
and active constituents as demonstrated by our ﬁndings.
CONSORT (Consolidated Standards of Reporting Trials), a
statement describing the reporting of herbal interventions,
serves to raise awareness to the importance of reporting this
information to stakeholders involved in all phases of the
research process [15],andTilburtandKaptchuk2008suggest
many researchers already recognise the need to establish a
rational basis for dosing and standardisation of biological
active compounds before initiating large treatment trials
[16].
It was encouraging to ﬁnd the majority of researchers
did not need to make signiﬁcant amendments to their study
protocols, however, among those reporting a need to make
changes risk and risk management were recurring themes.
HRECs reported insuﬃcient information was presented on
safety when combining herbal ingredients, claim of formula,6 Evidence-Based Complementary and Alternative Medicine
drug-herb interactions, and product quality of herbs. This
mirrored feedback from researchers indicating they were
requested to provide additional information on the charac-
terisation, stability, and standardisation of herbal products
safety and risks from acupuncture. Overall adherence with
other ethical principles was high and less problematic.
HRECs identiﬁed 20% of research applications received
having a conﬂict of interest relating to ﬁnancial interests or
personalbeneﬁtwhich mayleadtotheresearch processbeing
compromised.
Lack of disclosure to research participants about the use
of placebo acupuncture has been reported in four RCTs
published in leading medical journals [17], and a review
of acupuncture placebo controlled trials [18]. Trials where
participants were told they would be randomly assigned to
diﬀerent forms of acupuncture rather than a placebo control
havebeendescribedas“deceptivedisclosure”.Thiswasnotan
area of acupuncture research identiﬁed as having an ethical
concern in our study.
There has beena perceptionthat some ethicscommittees
may bebiased against CMresearch [9],however, the ﬁndings
from our study do not support this view. The majority
of HRECs appeared to have access to expertise (although
the criteria of expertise remains unclear) to review TCM
or WHM applications when the need arose. Whilst our
ﬁndings provide very few cases of research being dismissed
due to scientiﬁc rigour, there is no data to ascertain if these
applications were unfairly judged.
Researchers and members of HRECs expressed an inter-
estinreceiving further training. Two initiativesare underway
which will provide researchers and HRECs with useful
resources. Standard operating procedures (SOPs) relating to
TCM research and publication of frequently asked questions
are in the ﬁnal stages of development at The University of
Western Sydney, and these will be made widely available
in Australian and international TCM networks. Standard
operating procedures (SOPs) will develop and improve
operating procedures and will allow for certiﬁcation or an
accreditation programme in the future.
The limitations of our study primarily relate to the
response and participation rates. It is not known precisely
how many researchers have undertaken TCM or WHM
research in Australia. We were only able to target those
researchers for which we had contact details. Consequently it
is not possible to determine what proportion of researchers
the survey represents. A 50% response rate from researchers
suggests our ﬁndings may not be generalisable to all TCM
and WHM researchers. Selection bias must be considered,
a n di ti sp o s s i b l et h a to n l yt h emost motivated researchers
responded to the survey. We have limited data available
on the non responder and it is unclear if our results
reﬂect the experience of early or mid career researchers.
However, one comparison of the sex of responder and the
study population suggests responders were representative
of TCM and WHM researchers. In addition, responses
from researchers mirrored the geographical distribution
and the ethics review activity of HRECs. We consider
the geographical distribution of responding HRECs to be
representative of HRECs reviewing TCM and WHM ethics
applications in Australia.
Future research or replication of this study in other
geographical settings would be assisted by a census of
researchers active in respective disciplines. In addition, the
content validity of the questionnaire could be established
from piloting of the questionnaire in diﬀerent geographical
settings and with similar CM disciplines. We were unable to
validate responses from participants in our study due to the
lack of followup, and there was limited opportunity for in-
depth questioning relating to the type or extent of TCM and
WHM knowledge of HREC members. These areas could be
explored further using qualitative methods.
5.Conclusion
This study has shown that TCM and WHM researchers
and HRECs in Australia have valuable experience with the
submission and review of applications, and the majority
of researchers successfully negotiate the ethics processes.
Overall adherence with the principles of ethical conduct was
high among TCM and WHM researchers although our study
did identify some gaps mostly relating to the assessment of
risk and risk management.
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